cbdMDYCBD +6.34%38 OCF Margin % is -12.82% as of Mar. 2026. GuruFocus rates YCBD with a GF Score™ of 38/100 and a GF Value™ of $0.16 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 959 Drug Manufacturers companies, cbdMD ranks worse than 83.52% on this metric.
OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. cbdMD's Cash Flow from Operations for the
three
months ended in Mar. 2026 was $-0.72 Mil. cbdMD's Revenue for the
three
months ended in Mar. 2026 was $5.64 Mil. Therefore, cbdMD's OCF Margin % for the quarter that ended in Mar. 2026 was -12.82%.
The historical rank and industry rank for cbdMD's OCF Margin % or its related term are showing as below:
YCBD'
s OCF Margin % Range Over the Past 10 Years
Min: -1214.16 Med: -36.98 Max: -1.81
Current: -12.41
During the past 11 years, the highest OCF Margin % of cbdMD was -1.81%. The lowest was -1214.16%. And the median was -36.98%.
YCBD's OCF Margin % is ranked worse than 83.52% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs YCBD: -12.41
cbdMD OCF Margin % Related Terms
cbdMD OCF Margin % Historical Data
* Premium members only.
The historical data trend for cbdMD's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
cbdMD OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, cbdMD's OCF Margin % distribution charts can be found below:
* The bar in red indicates where cbdMD's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
cbdMD (YCBD) has a OCF Margin % of -12.82% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on cbdMD and its competitors. According to the industry distribution chart, cbdMD ranks #801 out of 959 companies in the Drug Manufacturers industry, placing it in the top 83.5%.
Is cbdMD's OCF Margin % too high?
cbdMD's current OCF Margin % is -12.82%. Based on the distribution chart, cbdMD ranks #801 out of 959 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, cbdMD has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does cbdMD's OCF Margin % compare to SXTC and CABR?
According to the Drug Manufacturers industry distribution chart, cbdMD ranks #801 out of 959 companies for OCF Margin %. This places cbdMD in the lower half of its industry. The industry median OCF Margin % is 9.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on cbdMD and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. cbdMD's current OCF Margin % is -12.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is cbdMD stock overvalued right now?
Based on GuruFocus' analysis, cbdMD (YCBD) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.16, compared to a current price of $0.70 — trading 339.4% above its estimated fair value. The current OCF Margin % is -12.82%. cbdMD's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For cbdMD (YCBD), the current OCF Margin % is -12.82% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is cbdMD (YCBD) Overvalued in 2026?
Based on GuruFocus' analysis, cbdMD stock appears to be overvalued.
The current stock price of $0.70 is trading 339.4% above its estimated GF Value™ of $0.16.
GuruFocus considers cbdMD to be Significantly Overvalued.
Key valuation signals for YCBD:
OCF Margin %: -12.82%
GF Value™: $0.16 vs. price of $0.70 (339.4% above fair value)
No single metric tells the full story. See the YCBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
38GF Score
Get the complete analysis for YCBD
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YCBD has been successfully added to your 
